Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex.

Saved in:
Bibliographic Details
Title: Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex.
Authors: Miranda-Azpiazu P; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain., Muguruza C; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain., Stepniewski TM; Research Programme on Biomedical Informatics, Hospital del Mar Research Institute, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain; InterAx Biotech AG, PARK InnovAARE, Villigen, Switzerland; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland., Muneta-Arrate I; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain., Moreira D; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Kaertor Foundation, Santiago de Compostela, Spain., Brea J; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Callado LF; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Loza MI; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Kaertor Foundation, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., González-Maeso J; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia., Selent J; Research Programme on Biomedical Informatics, Hospital del Mar Research Institute, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain., Diez-Alarcia R; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Meana JJ; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. Electronic address: javier.meana@ehu.eus.
Source: Molecular pharmacology [Mol Pharmacol] 2025 Nov; Vol. 107 (11), pp. 100075. Date of Electronic Publication: 2025 Sep 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0035623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0111 (Electronic) Linking ISSN: 0026895X NLM ISO Abbreviation: Mol Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41135363
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Distinctive patterns of G protein coupling induced by the structurally similar 5-HT<subscript>2A</subscript> receptor ligands ketanserin and altanserin in human prefrontal cortex.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Miranda-Azpiazu+P%22">Miranda-Azpiazu P</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.<br /><searchLink fieldCode="AU" term="%22Muguruza+C%22">Muguruza C</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain.<br /><searchLink fieldCode="AU" term="%22Stepniewski+TM%22">Stepniewski TM</searchLink>; Research Programme on Biomedical Informatics, Hospital del Mar Research Institute, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain; InterAx Biotech AG, PARK InnovAARE, Villigen, Switzerland; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Muneta-Arrate+I%22">Muneta-Arrate I</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain.<br /><searchLink fieldCode="AU" term="%22Moreira+D%22">Moreira D</searchLink>; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Kaertor Foundation, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Brea+J%22">Brea J</searchLink>; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Callado+LF%22">Callado LF</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.<br /><searchLink fieldCode="AU" term="%22Loza+MI%22">Loza MI</searchLink>; Innopharma Drug Screening and Pharmacogenomics Platform, BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain; Kaertor Foundation, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22González-Maeso+J%22">González-Maeso J</searchLink>; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia.<br /><searchLink fieldCode="AU" term="%22Selent+J%22">Selent J</searchLink>; Research Programme on Biomedical Informatics, Hospital del Mar Research Institute, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Diez-Alarcia+R%22">Diez-Alarcia R</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.<br /><searchLink fieldCode="AU" term="%22Meana+JJ%22">Meana JJ</searchLink>; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Spain; Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. Electronic address: javier.meana@ehu.eus.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220035623%22">Molecular pharmacology</searchLink> [Mol Pharmacol] 2025 Nov; Vol. 107 (11), pp. 100075. <i>Date of Electronic Publication: </i>2025 Sep 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%22">American Society for Pharmacology and Experimental Therapeutics </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0035623 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0111 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220026895X%22">0026895X </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41135363
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.molpha.2025.100075
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100075
    Titles:
      – TitleFull: Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miranda-Azpiazu P
      – PersonEntity:
          Name:
            NameFull: Muguruza C
      – PersonEntity:
          Name:
            NameFull: Stepniewski TM
      – PersonEntity:
          Name:
            NameFull: Muneta-Arrate I
      – PersonEntity:
          Name:
            NameFull: Moreira D
      – PersonEntity:
          Name:
            NameFull: Brea J
      – PersonEntity:
          Name:
            NameFull: Callado LF
      – PersonEntity:
          Name:
            NameFull: Loza MI
      – PersonEntity:
          Name:
            NameFull: González-Maeso J
      – PersonEntity:
          Name:
            NameFull: Selent J
      – PersonEntity:
          Name:
            NameFull: Diez-Alarcia R
      – PersonEntity:
          Name:
            NameFull: Meana JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1521-0111
          Numbering:
            – Type: volume
              Value: 107
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular pharmacology
              Type: main
ResultId 1